Table 3.

Results of multiple logistic regression analyses: Eligibility for NSCLC clinical trials.

Covariates	OR (95% CI)	P value
Age, y <60 60–69 > = 70	ref 0.66 (0.26–1.63) 0.56 (0.20–1.51)	ref 0.36 0.25
Sex, % Male Female	ref 1.44 (0.63–3.32)	ref 0.39
Race White Black Other	ref 0.67 (0.22–2.06) 0.48 (0.13–1.79)	ref 0.49 0.27
Smoking status Never Former Current	ref 0.85 (0.29–2.48) 0.15 (0.03–0.64)	ref 0.77 0.01
Stage and line of treatment Stage 1 or 2 Stage 3 Stage 4: first line therapy Stage 4: second line therapy or greater	ref 0.36 (0.06–2.30) 4.43 (0.99–19.94) 5.18 (1.08–24.75)	ref 0.28 0.05 0.04
Type of initial appointment Diagnosis or treatment Consult only	ref 1.32 (0.57–3.07)	ref 0.51

Wald Test: Age (p = 0.47), Race (p = 0.44), Smoking status (p = 0.02), and Stage-and-line of treatment (p < 0.0001).